Document is current
Any future updates will be listed below
-
Authors
Schweizer, Michael T. https://orcid.org/0000-0002-5510-0661
Gulati, Roman https://orcid.org/0000-0002-7592-6567
Yezefski, Todd
Cheng, Heather H. https://orcid.org/0000-0002-1365-0702
Mostaghel, Elahe
Haffner, Michael C.
Patel, Radhika A.
De Sarkar, Navonil
Ha, Gavin
Dumpit, Ruth
Woo, Brianna
Lin, Aaron
Panlasigui, Patrick https://orcid.org/0000-0002-1428-1742
McDonald, Nerina
Lai, Michael
Nega, Katie
Hammond, Jeannette
Grivas, Petros
Hsieh, Andrew https://orcid.org/0000-0002-0897-1050
Montgomery, Bruce
Nelson, Peter S. https://orcid.org/0000-0002-5451-5726
Yu, Evan Y.
-
Funding
Funding for this research was provided by:
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH-16-1-0484)
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH-20-1-0111)
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH-21-1-0229)
Prostate Cancer Foundation
AstraZeneca
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R50 CA221836)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA015704)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA015704)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50 CA097186)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5P01 CA163227)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA266452-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (PC200262)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Doris Duke Charitable Foundation (2021184)
V Foundation for Cancer Research
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 3 October 2022
Revised: 7 December 2022
Accepted: 13 December 2022
First Online: 23 December 2022
Competing interests
: MTS: Paid consultant and/or received Honoria from Sanofi, AstraZeneca, PharmaIn and Resverlogix. He has received research funding to his institution from Zenith Epigenetics, Bristol Myers Squibb, Merck, Immunomedics, Janssen, AstraZeneca, Pfizer, Madison Vaccines, Hoffman-La Roche, Tmunity, SignalOne Bio and Ambrx, Inc. HHC: Paid consultant for AstraZeneca. She received royalties from UpToDate. Research funds to her institution were from Clovis Oncology, Color Genomics, Janssen, Medivation, Promontory Therapeutics (formerly Phosplatin) and Sanofi. PSN: Paid consultant for Janssen and Pfizer. He received royalties from UpToDate, Research funds to his institution were from Janssen.
: This clinical study was approved by the Fred Hutchinson Cancer Center institutional review board. All research subjects provided informed consent prior to participating in this study.
